Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Lynch

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Molecular Cancer|May 13, 2009
Identification of the B-Raf/Mek/Erk MAP kinase pathway as a target for all-trans retinoic acid during skin cancer promotionSatish B Cheepala, Weihong Yin, Zanobia Syed, et al.
The Journal of Nutritional Biochemistry|May 6, 2014
Conjugated linoleic acid suppresses dendritic cell activation and subsequent Th17 responsesEve Draper, Joseph DeCourcey, Sarah C Higgins, et al.
British Journal of Haematology|May 30, 2018
Elotuzumab monotherapy in patients with smouldering multiple myeloma: a phase 2 studySundar Jagannath, Jacob Laubach, Ellice Wong, et al.
British Journal of Haematology|July 20, 2016
Elotuzumab in combination with thalidomide and low-dose dexamethasone: a phase 2 single-arm safety study in patients with relapsed/refractory multiple myelomaMaría-Victoria Mateos, Miguel Granell, Albert Oriol, et al.
Clinical and Vaccine Immunology : CVI|July 17, 2015
Profiling Humoral Immune Responses to Clostridium difficile-Specific Antigens by Protein Microarray AnalysisOla H Negm, Mohamed R Hamed, Elizabeth M Dilnot, et al.
International Journal of Molecular Sciences|May 14, 2025
Identification of eccDNA in Extracellular Vesicles Derived from Human Dermal Fibroblasts Through Nanopore SequencingBianca Simonassi-Paiva, Julia Alves Luz, Julia Hellena Ribeiro, et al.
Cancer Chemotherapy and Pharmacology|December 13, 2006
Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft modelsYong S Chang, Jalila Adnane, Pamela A Trail, et al.
Communications Biology|November 13, 2022
Microfluidic live tracking and transcriptomics of cancer-immune cell doublets link intercellular proximity and gene regulationBianca C T Flores, Smriti Chawla, Ning Ma, et al.
BMC Genomics|January 8, 2017
The nature and nurture of cell heterogeneity: accounting for macrophage gene-environment interactions with single-cell RNA-SeqQuin F Wills, Esther Mellado-Gomez, Rory Nolan, et al.
Oral Oncology|September 24, 2017
A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator's choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141Naomi Kiyota, Yasuhisa Hasegawa, Shunji Takahashi, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Molecular Cancer|May 13, 2009
Identification of the B-Raf/Mek/Erk MAP kinase pathway as a target for all-trans retinoic acid during skin cancer promotionSatish B Cheepala, Weihong Yin, Zanobia Syed, et al.
The Journal of Nutritional Biochemistry|May 6, 2014
Conjugated linoleic acid suppresses dendritic cell activation and subsequent Th17 responsesEve Draper, Joseph DeCourcey, Sarah C Higgins, et al.
British Journal of Haematology|May 30, 2018
Elotuzumab monotherapy in patients with smouldering multiple myeloma: a phase 2 studySundar Jagannath, Jacob Laubach, Ellice Wong, et al.
British Journal of Haematology|July 20, 2016
Elotuzumab in combination with thalidomide and low-dose dexamethasone: a phase 2 single-arm safety study in patients with relapsed/refractory multiple myelomaMaría-Victoria Mateos, Miguel Granell, Albert Oriol, et al.
Clinical and Vaccine Immunology : CVI|July 17, 2015
Profiling Humoral Immune Responses to Clostridium difficile-Specific Antigens by Protein Microarray AnalysisOla H Negm, Mohamed R Hamed, Elizabeth M Dilnot, et al.
International Journal of Molecular Sciences|May 14, 2025
Identification of eccDNA in Extracellular Vesicles Derived from Human Dermal Fibroblasts Through Nanopore SequencingBianca Simonassi-Paiva, Julia Alves Luz, Julia Hellena Ribeiro, et al.
Cancer Chemotherapy and Pharmacology|December 13, 2006
Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft modelsYong S Chang, Jalila Adnane, Pamela A Trail, et al.
Communications Biology|November 13, 2022
Microfluidic live tracking and transcriptomics of cancer-immune cell doublets link intercellular proximity and gene regulationBianca C T Flores, Smriti Chawla, Ning Ma, et al.
BMC Genomics|January 8, 2017
The nature and nurture of cell heterogeneity: accounting for macrophage gene-environment interactions with single-cell RNA-SeqQuin F Wills, Esther Mellado-Gomez, Rory Nolan, et al.
Oral Oncology|September 24, 2017
A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator's choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141Naomi Kiyota, Yasuhisa Hasegawa, Shunji Takahashi, et al.
Pageof 6